Data from Arteriosclerosis, Thrombosis and Vascular Biology - Curated by EPG Health - Date added 21 April 2017

The ISTH 2017 Congress, taking place July 8-13 in Berlin, Germany, brings together the world’s leading experts in thrombosis, hemostasis and vascular biology with a focus on understanding bleeding and clotting disorders to better serve patients. With an expected attendance of up to 10,000 delegates from 90 countries, ISTH 2017 will not only be the largest global meeting in thrombosis and hemostasis to date, but also among the largest scientific meetings hosted in Berlin. 

This year, an astounding 3,120 scientific abstracts from 83 countries were submitted by clinicians, scientists, academics and students for ISTH 2017, which is the second highest submission rate in the history of the meeting, following closely after ISTH 2007 in Geneva, Switzerland. Abstracts cover important topics such as atherothrombosis and stroke, coagulant and anticoagulant mechanisms, diagnostics, hemorrhagic disorders and hemophilia, management of thromboembolism, pediatrics, nursing and allied health, platelets, transfusion and biotherapeutics, vascular biology and much more.

“ISTH 2017 is on track to be the most impactful meeting of both the scientific community and industry for the presentation of scientific advances and therapeutic approaches,” said Congress President Johannes Oldenburg. “We look forward to convening the world’s experts to discuss new clinical applications designed to improve patient care around the globe.”

Registration for ISTH 2017 is now open. Visit to learn more. 

About the ISTH
Founded in 1969, the ISTH is the leading worldwide not-for-profit organization dedicated to advancing the understanding, prevention, diagnosis and treatment of thrombotic and bleeding disorders. ISTH is an international professional membership organization with more than 4,000 clinicians, researchers and educators working together to improve the lives of patients in more than 94 countries around the world. Among its highly regarded activities and initiatives are education and standardization programs, research activities, meetings and congresses, peer-reviewed publications, expert committees and World Thrombosis Day on 13 October. Visit ISTH online at


You will need to login, to leave a comment. is not monitored for collection of adverse event reports. Any adverse events should be reported to your national reporting agency and/or the manufacturer.

Learning Zones

An Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Oral Anticoagulation Reversal

Oral Anticoagulation Reversal

Experts discuss the use of non-vitamin K oral anticoagulants in the treatment and prevention of stroke, deep vein thrombosis and pulmonary embolism in atrial fibrillation patients.

Chronic Lymphocytic Leukaemia (CLL)

Chronic Lymphocytic Leukaemia (CLL)

Refine your knowledge of chronic lymphocytic leukaemia (CLL) with information on pathophysiology, diagnosis, treatment options and more

+ 1 more

Acute and Advanced Heart Failure

Acute and Advanced Heart Failure

What are the most effective treatments for acute heart failure? Can you define advanced heart failure? Discover here...

+ 3 more

Load more

Related Content